New Hope, PA – CRO Analytics, the leading provider of validated clinical trial performance data, announced a partnership with the Association of Clinical Research Professionals (ACRP) focused on measuring investigator site personnel views of clinical trial quality. The collaboration will provide critical insight into the quality of clinical trials, key drivers of that quality, and methods to improve clinical research.
CRO Analytics will develop a statistically validated data collection instrument to be used with the Performer™ platform, and work with ACRP to collect assessments from investigator site personnel. That data will be analyzed using the cloud-based SaaS software application through a series of algorithms and generate benchmarking, key driver analytics, and predictive analytics.
"We are thrilled to partner with such a prestigious organization that shares our mission of improving clinical research," said Peter Malamis, CEO of CRO Analytics. "The partnership enables us to add the input of key participants and stakeholders in clinical trials - personnel at investigative sites – to our measurement of trial quality. Analyzing this data through our Clinical Trial Quality System, Performer™, establishes a baseline of performance for benchmarking, key driver analytics, and predictive analytics. This can help all stakeholders understand what needs to be done to make clinical trials more efficient and effective."
"The prospect of establishing a benchmark for clinical trial quality has incredible potential for ACRP and we could not have done it without a Partner such as CRO Analytics. While sites will benefit greatly from this tool, we are eager to use aggregate data to pinpoint methods to further our mission to promote excellence in clinical research," said Terri Hinkley, Interim Executive Director of ACRP.
Throughout the partnership, CRO Analytics and ACRP will work together to develop and finalize the data collection instrument. A report of de-identified findings will be published following the conclusion of the initial project.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.